Today, the VP Finance and Principal Accounting Officer of Invitae (NYSE: NVTA), Patty Dumond, sold shares of NVTA for $10.7K.
Following Patty Dumond’s last NVTA Sell transaction on February 15, 2017, the stock climbed by 6.8%. In addition to Patty Dumond, one other NVTA executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Invitae’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $37.31 million and GAAP net loss of $31.67 million. In comparison, last year the company earned revenue of $14.34 million and had a GAAP net loss of $28.56 million. Currently, Invitae has an average volume of 1.65M. The Company has a Price to Book ratio of 8.4027.
The insider sentiment on Invitae has been negative according to 19 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headuartered in San Francisco, CA.
